The global Metformin Hydrochloride market was valued USD XXX MN (by revenue) in 2018. The report foresees this market to reach USD XXX MN by 2025 and register a CAGR of X.X% from 2019 to 2025.
 
Metformin hydrochloride is an antihyperglycemic drug that improves glucose tolerance and has potential antineoplastic property. It is mainly used as a first-line medication to the treatment of type-2 diabetes. It is a white colored crystalline powder soluble in water but insoluble in acetone, ether and chloroform.
 
Market Dynamics
 
Drivers:

• Growing prevalence of diabetes
• Rising aged population

 
Restraints:

• Side effects associated with the drug

 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of metformin hydrochloride.
 
Market Segmentation
 
The broad metformin hydrochloride market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

• Metformin HCl
• Metformin DC

 
By Application

• Metformin Hydrochloride Tablets
• Metformin Hydrochloride Extended-Release Tablets
• Others Form

 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for metaformin hydrochloride in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Metformin Hydrochloride Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the metformin hydrochloride market include Aarti Drugs, Bristol-Mayers Squibb, CR Double-Crane, FARMHISPANIA GROUP, Harman Finochem, Keyuan Pharmaceutical, Merck Sante, Shijiazhuang Polee Pharmaceutical, Shouguang Fukang Pharmaceutical, Taj API, TEVA, Vistin Pharma and Wanbury among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
Manufacturing Cost Analysis
 
The Metformin hydrochloride Market Manufacturing Cost Analysis included in the report provides data on raw materials, labor cost and other manufacturing expenses. This analysis assists in cost management and cost regularizing as per the industry trends.
 
Marketing Channel
 
The detailed analysis of the marketing channel prominently used in Metformin hydrochloride market is also covered in the report.  The data is covered as direct marketing, indirect marketing and marketing channel development trends.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.